Correlation Between Syndax Pharmaceuticals and Spyre Therapeutics
Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syndax Pharmaceuticals and Spyre Therapeutics, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Spyre Therapeutics.
Diversification Opportunities for Syndax Pharmaceuticals and Spyre Therapeutics
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Syndax and Spyre is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Spyre Therapeutics go up and down completely randomly.
Pair Corralation between Syndax Pharmaceuticals and Spyre Therapeutics
Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to under-perform the Spyre Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Syndax Pharmaceuticals is 5.08 times less risky than Spyre Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Spyre Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 850.00 in Spyre Therapeutics on December 5, 2024 and sell it today you would earn a total of 972.00 from holding Spyre Therapeutics or generate 114.35% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Syndax Pharmaceuticals vs. Spyre Therapeutics
Performance |
Timeline |
Syndax Pharmaceuticals |
Spyre Therapeutics |
Syndax Pharmaceuticals and Spyre Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Syndax Pharmaceuticals and Spyre Therapeutics
The main advantage of trading using opposite Syndax Pharmaceuticals and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
Spyre Therapeutics vs. Barrick Gold Corp | Spyre Therapeutics vs. Alto Neuroscience, | Spyre Therapeutics vs. Avarone Metals | Spyre Therapeutics vs. Senmiao Technology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |